Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Bamako, Mali: A Population-Based Cross-Sectional Study in September 2022

被引:0
作者
Traore, Bourama [1 ]
Guindo, Merepen A. [1 ]
Konate, Drissa [1 ]
Kane, Fousseyni [1 ]
Incandela, Nathan C. [2 ]
Traore, Abdouramane [1 ]
Kante, Salimata [1 ]
Sidibe, Mariam [1 ]
Keita, Bourama [1 ]
Kasse, Fatoumata [1 ]
Tangara, Karamoko [1 ]
Diallo, Dramane [1 ]
Maiga, Issoufi Y. [1 ]
Thiam, Salif [1 ]
Cisse, Abdourhamane [1 ]
Siby, Khatry M. [1 ]
Dicko, Abdoul R. [3 ]
Goita, Mariam [3 ]
Kone, Diakaridia [4 ]
Diallo, Mamadou [5 ]
Traore, Modibo [6 ]
Coulibaly, Yaya I. [1 ]
Diakite, Mahamadou [1 ]
Doumbia, Seydou [1 ]
Dolo, Housseini [1 ]
Balam, Saidou [1 ]
机构
[1] Univ Sci Tech & Technol Bamako USTTB, Univ Clin Res Ctr UCRC, Int Ctr Excellence Res ICER, Fac Med & Odontostomatol FMOS,Fac Pharm FAPHA, Bamako, Mali
[2] Univ Calif Santa Barbara, Ctr Polymers & Organ Solids, Dept Chem & Biochem, Santa Barbara, CA USA
[3] Dist Hlth Ctr Commune 4 Bamako, Minist Hlth & Social Dev Mali, Bamako, Mali
[4] Hosp Dist Hlth Commune 1 Bamako, Minist Hlth & Social Dev Mali, Bamako, Mali
[5] Dist Hlth Ctr Commune 6 Bamako, Minist Hlth & Social Dev Mali, Bamako, Mali
[6] Dist Hlth Ctr Commune 5 Bamako, Minist Hlth & Social Dev Mali, Bamako, Mali
关键词
associated factors; Bamako; Mali; SARS-CoV-2; antibodies; seroprevalence; COVID-19; SEX;
D O I
10.1111/irv.13343
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundThe sero-epidemiological characteristics of SARS-CoV-2 infections in Mali are not yet well understood. This study assessed SARS-CoV-2 antibody seroprevalence and factors associated with antibody responses in the general population of Bamako, the capital city and epicenter of COVID-19, to assess the magnitude of the pandemic and contribute to control strategy improvements in Mali.MethodsA cross-sectional survey was conducted in September 2022 to collect sociodemographic information, clinical characteristics, comorbid factors, and blood samples. ELISA was performed to determine anti-Spike (anti-S) and anti-RBD antibody levels. A total of 3601 participants were enrolled in REDCap. R-Studio was used for the statistical analysis. The chi-squared (chi 2) test was used to compare the proportions across different groups. Logistic regression models were used to elucidate factors associated with antibody responses.ResultThe sex ratio for female-to-male was 3.6:1. The most representative groups were the 20-29-year-olds (28.9%, n = 1043) and the 30-39-year-olds (26.9%, n = 967). The COVID-19 vaccine coverage among the participants was 35.8%, with vaccines from Covishield AstraZeneca (13.4%), Johnson & Johnson (16.7%), Sinovac (3.9%), and BioNTech Pfizer (1.8%). Overall, S protein and RBD antibody seroprevalences were remarkably high in the study population (98% and 97%, respectively). Factors such as youth (1-9 years old) and male sex were associated with lower SARS-CoV-2 antibody responses, whereas COVID-19 vaccinations were associated with increased antibody responses.ConclusionThis serosurvey demonstrated the high seroprevalence of SARS-CoV-2 antibodies and highlighted the factors influencing antibody responses, while clearly underlining an underestimation of the pandemic in Mali.
引用
收藏
页数:11
相关论文
共 38 条
[31]   Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas [J].
Traore, Abdouramane ;
Guindo, Merepen A. ;
Konate, Drissa ;
Traore, Bourama ;
Diakite, Seidina A. ;
Kante, Salimata ;
Dembele, Assitan ;
Cisse, Abdourhamane ;
Incandela, Nathan C. ;
Kodio, Mamoudou ;
Coulibaly, Yaya I. ;
Faye, Ousmane ;
Kajava, Andrey V. ;
Pratesi, Federico ;
Migliorini, Paola ;
Papini, Anna Maria ;
Pacini, Lorenzo ;
Rovero, Paolo ;
Errante, Fosca ;
Diakite, Mahamadou ;
Arevalo-Herrera, Myriam ;
Herrera, Socrates ;
Corradin, Giampietro ;
Balam, Saidou .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[32]   Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors [J].
Uyoga, Sophie ;
Adetifa, Ifedayo M. O. ;
Karanja, Henry K. ;
Nyagwange, James ;
Tuju, James ;
Wanjiku, Perpetual ;
Aman, Rashid ;
Mwangangi, Mercy ;
Amoth, Patrick ;
Kasera, Kadondi ;
Ng'ang'a, Wangari ;
Rombo, Charles ;
Yegon, Christine ;
Kithi, Khamisi ;
Odhiambo, Elizabeth ;
Rotich, Thomas ;
Orgut, Irene ;
Kihara, Sammy ;
Otiende, Mark ;
Bottomley, Christian ;
Mupe, Zonia N. ;
Kagucia, Eunice W. ;
Gallagher, Katherine E. ;
Etyang, Anthony ;
Voller, Shirine ;
Gitonga, John N. ;
Mugo, Daisy ;
Agoti, Charles N. ;
Otieno, Edward ;
Ndwiga, Leonard ;
Lambe, Teresa ;
Wright, Daniel ;
Barasa, Edwine ;
Tsofa, Benjamin ;
Bejon, Philip ;
Ochola-Oyier, Lynette, I ;
Agweyu, Ambrose ;
Scott, J. Anthony G. ;
Warimwe, George M. .
SCIENCE, 2021, 371 (6524) :79-82
[33]   Assessing the economic impact of COVID-19 on the private wildlife industry of South Africa [J].
van der Merwe, Peet ;
Saayman, Andrea ;
Jacobs, Chiree .
GLOBAL ECOLOGY AND CONSERVATION, 2021, 28
[34]   What Could Explain the Lower COVID-19 Burden in Africa despite Considerable Circulation of the SARS-CoV-2 Virus? [J].
Wamai, Richard G. ;
Hirsch, Jason L. ;
Van Damme, Wim ;
Alnwick, David ;
Bailey, Robert C. ;
Hodgins, Stephen ;
Alam, Uzma ;
Anyona, Mamka .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (16)
[35]   Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum [J].
Weisberg, Stuart P. ;
Connors, Thomas J. ;
Zhu, Yun ;
Baldwin, Matthew R. ;
Lin, Wen-Hsuan ;
Wontakal, Sandeep ;
Szabo, Peter A. ;
Wells, Steven B. ;
Dogra, Pranay ;
Gray, Joshua ;
Idzikowski, Emma ;
Stelitano, Debora ;
Bovier, Francesca T. ;
Davis-Porada, Julia ;
Matsumoto, Rei ;
Poon, Maya Meimei Li ;
Chait, Michael ;
Mathieu, Cyrille ;
Horvat, Branka ;
Decimo, Didier ;
Hudson, Krystalyn E. ;
Dei Zotti, Flavia ;
Bitan, Zachary C. ;
La Carpia, Francesca ;
Ferrara, Stephen A. ;
Mace, Emily ;
Milner, Joshua ;
Moscona, Anne ;
Hod, Eldad ;
Porotto, Matteo ;
Farber, Donna L. .
NATURE IMMUNOLOGY, 2021, 22 (01) :25-31
[36]   The COVID-19 wave was already here: High seroprevalence of SARS-CoV-2 antibodies among staff and students in a Cameroon University [J].
Wondeu, Andrillene Laure Deutou ;
Talom, Beatrice Metchum ;
Linardos, Giulia ;
Ngoumo, Barnes Tanetsop ;
Bello, Aichatou ;
Soufo, Aurele Marc Ndassi ;
Momo, Aime Cesaire ;
Doll, Christian ;
Tamuedjoun, Alaric Talom ;
Kiuate, Jules-Roger ;
Cappelli, Giulia ;
Russo, Cristina ;
Perno, Carlo Federico ;
Tchidjou, Hyppolite K. ;
Scaramella, Lucia ;
Galgani, Andrea .
JOURNAL OF PUBLIC HEALTH IN AFRICA, 2023, 14 (01)
[37]   Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali [J].
Woodford, John ;
Sagara, Issaka ;
Dicko, Alassane ;
Zeguime, Amatigue ;
Doucoure, M'Bouye ;
Kwan, Jennifer ;
Zaidi, Irfan ;
Doritchamou, Justin ;
Snow-Smith, Maryonne ;
Alani, Nada ;
Renn, Jonathan ;
Kosik, Ivan ;
Holly, Jaroslav ;
Yewdell, Jonathan ;
Esposito, Dominic ;
Sadtler, Kaitlyn ;
Duffy, Patrick .
JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (12) :2001-2009
[38]   A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex [J].
Zeng, Fanfan ;
Dai, Chan ;
Cai, Pengcheng ;
Wang, Jinbiao ;
Xu, Lei ;
Li, Jianyu ;
Hu, Guoyun ;
Wang, Zheng ;
Zheng, Fang ;
Wang, Lin .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) :2050-2054